These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5412426)

  • 21. [Treatment of rheumatoid arthritis with cyclophosphamide (Endoxan)].
    Jarlov NV; Sorensen K
    Ugeskr Laeger; 1971 Apr; 133(13):587-9. PubMed ID: 5554491
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chemotherapy of lung cancer at Iwate Medical College].
    Kimura T
    Gan No Rinsho; 1968 Jan; 14(1):61-4. PubMed ID: 5692165
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bladder cancer and malignant melanoma following Endoxan therapy of a lymphoproliferative disease].
    Kaufmann B; Wegmann W
    Schweiz Med Wochenschr; 1981 Apr; 111(15):540-5. PubMed ID: 7233132
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
    Pisoni MB; Libretti A; Piazza E; Vago G; Scapaticci R; Bianchi C; Tomirotti M; Scanni A; Calzavara MP; Cassani L; Scarpazza G; Marsoni S; Morasca L
    Cancer Treat Rep; 1981; 65(7-8):731-2. PubMed ID: 6788372
    [No Abstract]   [Full Text] [Related]  

  • 26. [Urothelial carcinoma of the bladder following cyclophosphamide therapy].
    Blume B; Rabe F; Theuring F
    Z Urol Nephrol; 1984 Jan; 77(1):7-9. PubMed ID: 6702330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitomycin-associated lung disease.
    Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
    Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cytostatic therapy of lung and pleural neoplasms].
    Martz G; Danczkay I
    Bibl Tuberc; 1965; 20():176-85. PubMed ID: 5877566
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative results of massive endoxan stoss therapy and treatment of malignant tumors with proresid].
    Gebhardt KH; Becher R
    Med Welt; 1967 Jul; 30():1705-7. PubMed ID: 5616405
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
    Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
    Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myelotoxicity due to cancer chemotherapy with special reference to autologous bone marrow transplantation].
    Nakamura S
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1195-202. PubMed ID: 6381786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.
    Bergsagel DE; Robertson GL; Hasselback R
    Can Med Assoc J; 1968 Mar; 98(11):532-8. PubMed ID: 5643297
    [No Abstract]   [Full Text] [Related]  

  • 34. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
    Green MR
    J Clin Oncol; 2008 Jul; 26(19):3112-3. PubMed ID: 18591551
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide].
    Krawczyk K; Krochmal M; Pawlicki M; Kulpa J; Zielezińska A
    Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054
    [No Abstract]   [Full Text] [Related]  

  • 36. [Incidence and degree of intolerance and toxic effect of cytostatics in the treatment of lung cancer].
    Traczyk K; Zych D; Decker E; Radziukiewicz-Byszewska D; Krychniak W; Marzinek M; Pecyna-Sielewicz J; Ponahajba A; Siekierzyńska A; Słupek A
    Pneumonol Pol; 1980; 48(12):831-40. PubMed ID: 7220354
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
    Cadman EC; Glick JH; Cross J; Horton J; Taylor SG
    Cancer Treat Rep; 1984 Jun; 68(6):877-9. PubMed ID: 6547367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of cytostatics on tumor cells].
    Sergel' OS; Kopeĭko IP; Kachkov AP
    Sov Med; 1980; (12):53-6. PubMed ID: 6784250
    [No Abstract]   [Full Text] [Related]  

  • 40. [Observations on the therapy of primary cancer of the lung (sample research on 100 subjects treated)].
    Massei V
    Rass Int Clin Ter; 1967 Jun; 47(12):642-50. PubMed ID: 5607587
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.